| James Joseph Mcguire Jr, MD | |
|
701 Ostrum Street, Suite 501, Bethlehem, PA 18015 | |
| (610) 867-6161 | |
| (610) 868-9931 |
| Full Name | James Joseph Mcguire Jr |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 44 Years |
| Location | 701 Ostrum Street, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295848778 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD025655E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| St Luke's Hospital - Anderson Campus | Easton, PA | Hospital |
| St Lukes Quakertown Hospital | Quakertown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Luke's Physician Group Inc | 6709798333 | 1739 |
News Archive
Isconova AB, a leading international vaccine adjuvant company and Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell‐based vaccines, today announced the expansion of their collaboration granting Genocea the right to use Isconova's Matrix M in vaccines targeting two additional diseases.
Chronic conditions such as diabetes mellitus (DM), coronary artery disease (CAD), and cerebrovascular disease (CVD) have been associated with periodontal disease.
Patients using inhaled steroids to control asthma and other breathing problems may be at greater risk for developing nontuberculous mycobacteria lung infections, according to new research published online in the Annals of the American Thoracic Society.
New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow science to adjust microbiomes-the one-of-a-kind microbial communities that live in our gastrointestinal tracts-to help ward off serious chronic diseases.
› Verified 8 days ago
| Entity Name | St Luke's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508874538 PECOS PAC ID: 0648189688 Enrollment ID: O20031106000233 |
News Archive
Isconova AB, a leading international vaccine adjuvant company and Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell‐based vaccines, today announced the expansion of their collaboration granting Genocea the right to use Isconova's Matrix M in vaccines targeting two additional diseases.
Chronic conditions such as diabetes mellitus (DM), coronary artery disease (CAD), and cerebrovascular disease (CVD) have been associated with periodontal disease.
Patients using inhaled steroids to control asthma and other breathing problems may be at greater risk for developing nontuberculous mycobacteria lung infections, according to new research published online in the Annals of the American Thoracic Society.
New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow science to adjust microbiomes-the one-of-a-kind microbial communities that live in our gastrointestinal tracts-to help ward off serious chronic diseases.
› Verified 8 days ago
| Entity Name | St Luke's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326118126 PECOS PAC ID: 0648189688 Enrollment ID: O20031208000003 |
News Archive
Isconova AB, a leading international vaccine adjuvant company and Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell‐based vaccines, today announced the expansion of their collaboration granting Genocea the right to use Isconova's Matrix M in vaccines targeting two additional diseases.
Chronic conditions such as diabetes mellitus (DM), coronary artery disease (CAD), and cerebrovascular disease (CVD) have been associated with periodontal disease.
Patients using inhaled steroids to control asthma and other breathing problems may be at greater risk for developing nontuberculous mycobacteria lung infections, according to new research published online in the Annals of the American Thoracic Society.
New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow science to adjust microbiomes-the one-of-a-kind microbial communities that live in our gastrointestinal tracts-to help ward off serious chronic diseases.
› Verified 8 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
Isconova AB, a leading international vaccine adjuvant company and Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell‐based vaccines, today announced the expansion of their collaboration granting Genocea the right to use Isconova's Matrix M in vaccines targeting two additional diseases.
Chronic conditions such as diabetes mellitus (DM), coronary artery disease (CAD), and cerebrovascular disease (CVD) have been associated with periodontal disease.
Patients using inhaled steroids to control asthma and other breathing problems may be at greater risk for developing nontuberculous mycobacteria lung infections, according to new research published online in the Annals of the American Thoracic Society.
New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow science to adjust microbiomes-the one-of-a-kind microbial communities that live in our gastrointestinal tracts-to help ward off serious chronic diseases.
› Verified 8 days ago
| Entity Name | Star Community Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033686159 PECOS PAC ID: 7618215237 Enrollment ID: O20190206002009 |
News Archive
Isconova AB, a leading international vaccine adjuvant company and Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell‐based vaccines, today announced the expansion of their collaboration granting Genocea the right to use Isconova's Matrix M in vaccines targeting two additional diseases.
Chronic conditions such as diabetes mellitus (DM), coronary artery disease (CAD), and cerebrovascular disease (CVD) have been associated with periodontal disease.
Patients using inhaled steroids to control asthma and other breathing problems may be at greater risk for developing nontuberculous mycobacteria lung infections, according to new research published online in the Annals of the American Thoracic Society.
New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow science to adjust microbiomes-the one-of-a-kind microbial communities that live in our gastrointestinal tracts-to help ward off serious chronic diseases.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Joseph Mcguire Jr, MD 701 Ostrum Street, Suite 501, Bethlehem, PA 18015 Ph: (610) 867-6161 | James Joseph Mcguire Jr, MD 701 Ostrum Street, Suite 501, Bethlehem, PA 18015 Ph: (610) 867-6161 |
News Archive
Isconova AB, a leading international vaccine adjuvant company and Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell‐based vaccines, today announced the expansion of their collaboration granting Genocea the right to use Isconova's Matrix M in vaccines targeting two additional diseases.
Chronic conditions such as diabetes mellitus (DM), coronary artery disease (CAD), and cerebrovascular disease (CVD) have been associated with periodontal disease.
Patients using inhaled steroids to control asthma and other breathing problems may be at greater risk for developing nontuberculous mycobacteria lung infections, according to new research published online in the Annals of the American Thoracic Society.
New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow science to adjust microbiomes-the one-of-a-kind microbial communities that live in our gastrointestinal tracts-to help ward off serious chronic diseases.
› Verified 8 days ago
Carolyn Botros, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1770 Bathgate Rd Ste 401, Bethlehem, PA 18017 Phone: 484-884-8840 Fax: 484-884-8827 | |
Megan Dowd, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-503-8217 | |
Dr. Emer Colalillo, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 834 Eaton Ave, Bethlehem, PA 18018 Phone: 484-526-7474 | |
Sarah Jane Cathryn Muder, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-503-8217 | |
Dr. Anita Sargent, M.D., PH.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 325 W Broad St, 3rd Floor, Bethlehem, PA 18018 Phone: 424-626-9250 Fax: 484-626-9255 | |
Dr. Kathleen Eleanor Ackert, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4670 | |
Dr. John Roizin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 31 S Commerce Way, Bethlehem, PA 18017 Phone: 484-821-0821 Fax: 484-821-0826 |